Respiratory disease
Conditions
Interventions
Experimental group:Sequential method
Sponsors
Hainan Cancer Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1.Patients who intend to be examined and treated by fiberoptic bronchoscopy; 2.At the ASA I~II level; 3.The age is 18 to 65 years old; 4.The patient signed the informed consent form.
Exclusion criteria
Exclusion criteria: 1.Obesity (body mass index > 30kg/m^2); 2.Patients with recent bronchial asthma or massive hemoptysis; 3.patients with severe stenosis of the main airway; 4.Patients with myasthenia gravis; 5.Patients with schizophrenia; 6.Patients with severe depression or with a long history of benzodiazepine use; 7.Patients who are scheduled to be examined/ treated with fiberoptic bronchoscopy for more than 30 minutes.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Incidence of serious adverse events;Incidence of solicited adverse events;Incidence of unsolicited adverse events; | — |
Countries
China
Contacts
Public ContactJia Zhen
Hainan Cancer Hospital
Outcome results
None listed